Loading…
Norcolut with immune modulators in the complex treatment for hyperplastic uterine processes
The results are presented of the treatment of 55 patients for hyperplastic endometrial processes with the preparation norcolut combined with the immune modulators thymalinum and myelopidum. It was found that the application of the suggested schemes of the introduction of the medicines mentioned incr...
Saved in:
| Published in: | Clinical and experimental obstetrics & gynecology 1993, Vol.20 (1), p.13 |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | |
| container_issue | 1 |
| container_start_page | 13 |
| container_title | Clinical and experimental obstetrics & gynecology |
| container_volume | 20 |
| creator | Zaporozhan, V N Khait, O V Tumasyan, K P |
| description | The results are presented of the treatment of 55 patients for hyperplastic endometrial processes with the preparation norcolut combined with the immune modulators thymalinum and myelopidum. It was found that the application of the suggested schemes of the introduction of the medicines mentioned increase the treatment effectiveness and enlarges its possibilities. |
| format | article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_8462182</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>8462182</sourcerecordid><originalsourceid>FETCH-LOGICAL-p121t-f81b034677a24add3b0a7b90e5fda6c0e2a51f42cab63669d4f563a609fa973b3</originalsourceid><addsrcrecordid>eNotj8tKxDAUQLNQxnH0E4T8QCGvpu1SBl8w6EZXLoab5IZWmiYkKTp_r-CszuocOBdky-TAGq21vCLXpXwxplSn-YZseqUF78WWfL7GbOO8Vvo91ZFOIawL0hDdOkONudBpoXVEamNIM_7QmhFqwKVSHzMdTwlzmqHUydK1Yp7-5JSjxVKw3JBLD3PB2zN35OPx4X3_3Bzenl7294cmccFr43tumFS660AocE4aBp0ZGLbegbYMBbTcK2HBaKn14JRvtQTNBg9DJ43ckbv_blpNQHdMeQqQT8fzpPwFGRlPig</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Norcolut with immune modulators in the complex treatment for hyperplastic uterine processes</title><source>EZB Free E-Journals</source><creator>Zaporozhan, V N ; Khait, O V ; Tumasyan, K P</creator><creatorcontrib>Zaporozhan, V N ; Khait, O V ; Tumasyan, K P</creatorcontrib><description>The results are presented of the treatment of 55 patients for hyperplastic endometrial processes with the preparation norcolut combined with the immune modulators thymalinum and myelopidum. It was found that the application of the suggested schemes of the introduction of the medicines mentioned increase the treatment effectiveness and enlarges its possibilities.</description><identifier>ISSN: 0390-6663</identifier><identifier>PMID: 8462182</identifier><language>eng</language><publisher>Canada</publisher><subject>Activins ; Adjuvants, Immunologic - administration & dosage ; Adjuvants, Immunologic - adverse effects ; Adjuvants, Immunologic - therapeutic use ; Adult ; Drug Combinations ; Endometrial Hyperplasia - blood ; Endometrial Hyperplasia - drug therapy ; Estradiol - blood ; Female ; Follicle Stimulating Hormone - blood ; Follow-Up Studies ; Humans ; Immunoglobulin A - blood ; Immunoglobulin G - blood ; Immunoglobulin M - blood ; Injections, Intramuscular ; Luteinizing Hormone - blood ; Menstruation - drug effects ; Norethindrone - administration & dosage ; Norethindrone - adverse effects ; Norethindrone - therapeutic use ; Oligopeptides ; Peptides - administration & dosage ; Peptides - adverse effects ; Peptides - therapeutic use ; Progesterone - blood ; Thymus Hormones - administration & dosage ; Thymus Hormones - adverse effects ; Thymus Hormones - therapeutic use</subject><ispartof>Clinical and experimental obstetrics & gynecology, 1993, Vol.20 (1), p.13</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8462182$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zaporozhan, V N</creatorcontrib><creatorcontrib>Khait, O V</creatorcontrib><creatorcontrib>Tumasyan, K P</creatorcontrib><title>Norcolut with immune modulators in the complex treatment for hyperplastic uterine processes</title><title>Clinical and experimental obstetrics & gynecology</title><addtitle>Clin Exp Obstet Gynecol</addtitle><description>The results are presented of the treatment of 55 patients for hyperplastic endometrial processes with the preparation norcolut combined with the immune modulators thymalinum and myelopidum. It was found that the application of the suggested schemes of the introduction of the medicines mentioned increase the treatment effectiveness and enlarges its possibilities.</description><subject>Activins</subject><subject>Adjuvants, Immunologic - administration & dosage</subject><subject>Adjuvants, Immunologic - adverse effects</subject><subject>Adjuvants, Immunologic - therapeutic use</subject><subject>Adult</subject><subject>Drug Combinations</subject><subject>Endometrial Hyperplasia - blood</subject><subject>Endometrial Hyperplasia - drug therapy</subject><subject>Estradiol - blood</subject><subject>Female</subject><subject>Follicle Stimulating Hormone - blood</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Immunoglobulin A - blood</subject><subject>Immunoglobulin G - blood</subject><subject>Immunoglobulin M - blood</subject><subject>Injections, Intramuscular</subject><subject>Luteinizing Hormone - blood</subject><subject>Menstruation - drug effects</subject><subject>Norethindrone - administration & dosage</subject><subject>Norethindrone - adverse effects</subject><subject>Norethindrone - therapeutic use</subject><subject>Oligopeptides</subject><subject>Peptides - administration & dosage</subject><subject>Peptides - adverse effects</subject><subject>Peptides - therapeutic use</subject><subject>Progesterone - blood</subject><subject>Thymus Hormones - administration & dosage</subject><subject>Thymus Hormones - adverse effects</subject><subject>Thymus Hormones - therapeutic use</subject><issn>0390-6663</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><recordid>eNotj8tKxDAUQLNQxnH0E4T8QCGvpu1SBl8w6EZXLoab5IZWmiYkKTp_r-CszuocOBdky-TAGq21vCLXpXwxplSn-YZseqUF78WWfL7GbOO8Vvo91ZFOIawL0hDdOkONudBpoXVEamNIM_7QmhFqwKVSHzMdTwlzmqHUydK1Yp7-5JSjxVKw3JBLD3PB2zN35OPx4X3_3Bzenl7294cmccFr43tumFS660AocE4aBp0ZGLbegbYMBbTcK2HBaKn14JRvtQTNBg9DJ43ckbv_blpNQHdMeQqQT8fzpPwFGRlPig</recordid><startdate>1993</startdate><enddate>1993</enddate><creator>Zaporozhan, V N</creator><creator>Khait, O V</creator><creator>Tumasyan, K P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>1993</creationdate><title>Norcolut with immune modulators in the complex treatment for hyperplastic uterine processes</title><author>Zaporozhan, V N ; Khait, O V ; Tumasyan, K P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p121t-f81b034677a24add3b0a7b90e5fda6c0e2a51f42cab63669d4f563a609fa973b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Activins</topic><topic>Adjuvants, Immunologic - administration & dosage</topic><topic>Adjuvants, Immunologic - adverse effects</topic><topic>Adjuvants, Immunologic - therapeutic use</topic><topic>Adult</topic><topic>Drug Combinations</topic><topic>Endometrial Hyperplasia - blood</topic><topic>Endometrial Hyperplasia - drug therapy</topic><topic>Estradiol - blood</topic><topic>Female</topic><topic>Follicle Stimulating Hormone - blood</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Immunoglobulin A - blood</topic><topic>Immunoglobulin G - blood</topic><topic>Immunoglobulin M - blood</topic><topic>Injections, Intramuscular</topic><topic>Luteinizing Hormone - blood</topic><topic>Menstruation - drug effects</topic><topic>Norethindrone - administration & dosage</topic><topic>Norethindrone - adverse effects</topic><topic>Norethindrone - therapeutic use</topic><topic>Oligopeptides</topic><topic>Peptides - administration & dosage</topic><topic>Peptides - adverse effects</topic><topic>Peptides - therapeutic use</topic><topic>Progesterone - blood</topic><topic>Thymus Hormones - administration & dosage</topic><topic>Thymus Hormones - adverse effects</topic><topic>Thymus Hormones - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zaporozhan, V N</creatorcontrib><creatorcontrib>Khait, O V</creatorcontrib><creatorcontrib>Tumasyan, K P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Clinical and experimental obstetrics & gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zaporozhan, V N</au><au>Khait, O V</au><au>Tumasyan, K P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Norcolut with immune modulators in the complex treatment for hyperplastic uterine processes</atitle><jtitle>Clinical and experimental obstetrics & gynecology</jtitle><addtitle>Clin Exp Obstet Gynecol</addtitle><date>1993</date><risdate>1993</risdate><volume>20</volume><issue>1</issue><spage>13</spage><pages>13-</pages><issn>0390-6663</issn><abstract>The results are presented of the treatment of 55 patients for hyperplastic endometrial processes with the preparation norcolut combined with the immune modulators thymalinum and myelopidum. It was found that the application of the suggested schemes of the introduction of the medicines mentioned increase the treatment effectiveness and enlarges its possibilities.</abstract><cop>Canada</cop><pmid>8462182</pmid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0390-6663 |
| ispartof | Clinical and experimental obstetrics & gynecology, 1993, Vol.20 (1), p.13 |
| issn | 0390-6663 |
| language | eng |
| recordid | cdi_pubmed_primary_8462182 |
| source | EZB Free E-Journals |
| subjects | Activins Adjuvants, Immunologic - administration & dosage Adjuvants, Immunologic - adverse effects Adjuvants, Immunologic - therapeutic use Adult Drug Combinations Endometrial Hyperplasia - blood Endometrial Hyperplasia - drug therapy Estradiol - blood Female Follicle Stimulating Hormone - blood Follow-Up Studies Humans Immunoglobulin A - blood Immunoglobulin G - blood Immunoglobulin M - blood Injections, Intramuscular Luteinizing Hormone - blood Menstruation - drug effects Norethindrone - administration & dosage Norethindrone - adverse effects Norethindrone - therapeutic use Oligopeptides Peptides - administration & dosage Peptides - adverse effects Peptides - therapeutic use Progesterone - blood Thymus Hormones - administration & dosage Thymus Hormones - adverse effects Thymus Hormones - therapeutic use |
| title | Norcolut with immune modulators in the complex treatment for hyperplastic uterine processes |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T02%3A46%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Norcolut%20with%20immune%20modulators%20in%20the%20complex%20treatment%20for%20hyperplastic%20uterine%20processes&rft.jtitle=Clinical%20and%20experimental%20obstetrics%20&%20gynecology&rft.au=Zaporozhan,%20V%20N&rft.date=1993&rft.volume=20&rft.issue=1&rft.spage=13&rft.pages=13-&rft.issn=0390-6663&rft_id=info:doi/&rft_dat=%3Cpubmed%3E8462182%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p121t-f81b034677a24add3b0a7b90e5fda6c0e2a51f42cab63669d4f563a609fa973b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/8462182&rfr_iscdi=true |